These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 33263761)

  • 61. Memory impairment and Alzheimer's disease pathology in individuals with MCI who underestimate or overestimate their decline.
    Bregman N; Kavé G; Zeltzer E; Biran I;
    Int J Geriatr Psychiatry; 2020 May; 35(5):581-588. PubMed ID: 32011757
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Interaction between memory impairment and depressive symptoms can exacerbate anosognosia: a comparison of Alzheimer's disease with mild cognitive impairment.
    Oba H; Matsuoka T; Imai A; Fujimoto H; Kato Y; Shibata K; Nakamura K; Narumoto J
    Aging Ment Health; 2019 May; 23(5):595-601. PubMed ID: 29528693
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Diagnostic accuracy of CERAD total score in a Colombian cohort with mild cognitive impairment and Alzheimer's disease affected by E280A mutation on presenilin-1 gene.
    Aguirre-Acevedo DC; Jaimes-Barragán F; Henao E; Tirado V; Muñoz C; Reiman EM; Tariot PN; Langbaum JB; Lopera F
    Int Psychogeriatr; 2016 Mar; 28(3):503-10. PubMed ID: 26478578
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Investigation of triggering receptor expressed on myeloid cells 2 variant in the Wisconsin Registry for Alzheimer's Prevention.
    Engelman CD; Koscik RL; Jonaitis EM; Hermann BP; La Rue A; Sager MA
    Neurobiol Aging; 2014 Jun; 35(6):1252-4. PubMed ID: 24378087
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Cortical atrophy in presymptomatic Alzheimer's disease presenilin 1 mutation carriers.
    Quiroz YT; Stern CE; Reiman EM; Brickhouse M; Ruiz A; Sperling RA; Lopera F; Dickerson BC
    J Neurol Neurosurg Psychiatry; 2013 May; 84(5):556-61. PubMed ID: 23134660
    [TBL] [Abstract][Full Text] [Related]  

  • 66. The effect of rare variants in TREM2 and PLD3 on longitudinal cognitive function in the Wisconsin Registry for Alzheimer's Prevention.
    Engelman CD; Darst BF; Bilgel M; Vasiljevic E; Koscik RL; Jedynak BM; Johnson SC
    Neurobiol Aging; 2018 Jun; 66():177.e1-177.e5. PubMed ID: 29395285
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Clinical and psychological characteristics of the initial cohort of the Dominantly Inherited Alzheimer Network (DIAN).
    Storandt M; Balota DA; Aschenbrenner AJ; Morris JC
    Neuropsychology; 2014 Jan; 28(1):19-29. PubMed ID: 24219606
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Behavioral and Electrophysiological Correlates of Memory Binding Deficits in Patients at Different Risk Levels for Alzheimer's Disease.
    Pietto M; Parra MA; Trujillo N; Flores F; García AM; Bustin J; Richly P; Manes F; Lopera F; Ibáñez A; Baez S
    J Alzheimers Dis; 2016 Jun; 53(4):1325-40. PubMed ID: 27372640
    [TBL] [Abstract][Full Text] [Related]  

  • 69. The Value of Pre-Screening in the Alzheimer's Prevention Initiative (API) Autosomal Dominant Alzheimer's Disease Trial.
    Rios-Romenets S; Giraldo-Chica M; López H; Piedrahita F; Ramos C; Acosta-Baena N; Muñoz C; Ospina P; Tobón C; Cho W; Ward M; Langbaum JB; Tariot PN; Reiman EM; Lopera F
    J Prev Alzheimers Dis; 2018; 5(1):49-54. PubMed ID: 29405233
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Anosognosia for memory deficits in mild cognitive impairment: Insight into the neural mechanism using functional and molecular imaging.
    Vannini P; Hanseeuw B; Munro CE; Amariglio RE; Marshall GA; Rentz DM; Pascual-Leone A; Johnson KA; Sperling RA
    Neuroimage Clin; 2017; 15():408-414. PubMed ID: 28616381
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Accelerated long-term forgetting in presymptomatic autosomal dominant Alzheimer's disease: a cross-sectional study.
    Weston PSJ; Nicholas JM; Henley SMD; Liang Y; Macpherson K; Donnachie E; Schott JM; Rossor MN; Crutch SJ; Butler CR; Zeman AZ; Fox NC
    Lancet Neurol; 2018 Feb; 17(2):123-132. PubMed ID: 29413314
    [TBL] [Abstract][Full Text] [Related]  

  • 72. An 1H-MRS framework predicts the onset of Alzheimer's disease symptoms in PSEN1 mutation carriers.
    Londono AC; Castellanos FX; Arbelaez A; Ruiz A; Aguirre-Acevedo DC; Richardson AM; Easteal S; Lidbury BA; Arcos-Burgos M; Lopera F
    Alzheimers Dement; 2014 Sep; 10(5):552-61. PubMed ID: 24239247
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Anosognosia in Alzheimer disease: Disconnection between memory and self-related brain networks.
    Perrotin A; Desgranges B; Landeau B; Mézenge F; La Joie R; Egret S; Pélerin A; de la Sayette V; Eustache F; Chételat G
    Ann Neurol; 2015 Sep; 78(3):477-86. PubMed ID: 26085009
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Early Depressive Symptoms Predict Faster Dementia Progression in Autosomal-Dominant Alzheimer's Disease.
    Acosta-Baena N; Lopera-Gómez CM; Jaramillo-Elorza MC; Velilla-Jiménez L; Villegas-Lanau CA; Sepúlveda-Falla D; Arcos-Burgos M; Lopera F
    J Alzheimers Dis; 2023; 92(3):911-923. PubMed ID: 36847011
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Memory performance and fMRI signal in presymptomatic familial Alzheimer's disease.
    Braskie MN; Medina LD; Rodriguez-Agudelo Y; Geschwind DH; Macias-Islas MA; Thompson PM; Cummings JL; Bookheimer SY; Ringman JM
    Hum Brain Mapp; 2013 Dec; 34(12):3308-19. PubMed ID: 22806961
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Phenotypic profile of early-onset familial Alzheimer's disease caused by presenilin-1 E280A mutation.
    Sepulveda-Falla D; Glatzel M; Lopera F
    J Alzheimers Dis; 2012; 32(1):1-12. PubMed ID: 22766738
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Association between white matter hyperintensity severity and cognitive impairment according to the presence of the apolipoprotein E (APOE) ε4 allele in the elderly: retrospective analysis of data from the CREDOS study.
    Son SJ; Lee KS; Lee Y; Baek JH; Choi SH; Na DL; Seo SW; Oh BH; Hong CH
    J Clin Psychiatry; 2012 Dec; 73(12):1555-62. PubMed ID: 23146133
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Antecedents and consequences of unawareness of memory impairment in dementia.
    Wilson RS; Barnes LL; Rajan KB; Boyle PA; Sytsma J; Weuve J; Evans DA
    Neuropsychology; 2018 Nov; 32(8):931-940. PubMed ID: 30047756
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Unawareness of cognitive deficit (cognitive anosognosia) in probable AD and control subjects.
    Barrett AM; Eslinger PJ; Ballentine NH; Heilman KM
    Neurology; 2005 Feb; 64(4):693-9. PubMed ID: 15728294
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Cognitive and functional neuroimaging correlate for anosognosia in mild cognitive impairment and Alzheimer's disease.
    Vogel A; Hasselbalch SG; Gade A; Ziebell M; Waldemar G
    Int J Geriatr Psychiatry; 2005 Mar; 20(3):238-46. PubMed ID: 15717342
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.